ARHGAP16P

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, ARHGAP16P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ARHGAP16P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where ARHGAP16P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ARHGAP16P is over-expressed in tumor.

BRCA and LUAD are the cancer types where ARHGAP16P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARHGAP16P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
BRCAAllAll+0.334<.0016view →
LUADMaleAll+0.018.0451view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ARHGAP16P–BRCA

Tumor-vs-normal expression box plot for ARHGAP16P RNA in BRCA.

Open the BRCA breakdown →

Exploration